“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...

Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for ...

On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace ...

In articulating SA’s ‘failed state’ discourse, Prof Maloka highlights that the focus is not political legitimacy or the state ...

Learn how San Diego-based Scripps Health effectively manages patient flow during flu season by utilizing internal transfers and leasing beds at skilled nursing ...

Becker's has reported on four hospitals and health systems that have promoted CFOs to the chief executive role in 2025.

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...